Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2007, Vol. 27 Issue (6): 6-9    DOI:
    
High Expression, Purification, Quality Control of rhEPO-Fc Fusion Protein
Download: HTML   PDF(503KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

To explore the technics for high expression, purification, quality control of recombinant human erythropoietin and IgG Fc fusion protein, rhEPO-Fc fusion protein expressed by CHO cells in serum-free medium was collected and purified with a three-step purification process-affinity chromatography, ion exchange chromatography and molecular sieve chromatography; and its quality was controlled by protein concentration、SDS-PAGE、Western-blot、HPLC、ELISA and IEF, et al. The research findings are that the expression output of rhEPO-Fc was highly reached 2g/L, the purify rate was over 45%, its purify was over 98%, its relative molecular weight is about 60KD, t1/2 in vivo of rhEPO-Fc is over 38h, western blot analysis showed rhEPO-Fc has nature antigenicity. The expression output and purify rate of the produce technics is high, quality inspection methods are stability and reliable, which could be fit for in large-scale production of rhEPO-Fc.



Key wordsRecombinant human erythropoietin      Fc segment of immunoglo- bulin G      Fusion protein      the technics of fermentor and purify      Quality control     
Received: 09 February 2007      Published: 25 June 2007
Cite this article:

. High Expression, Purification, Quality Control of rhEPO-Fc Fusion Protein. China Biotechnology, 2007, 27(6): 6-9.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2007/V27/I6/6

[1] LIU Guo-fang,LIU Xiao-zhi,GAO Jian,WANG Zhi-ming. Effects of Host Cell Residual Proteins on the Quality and Their Quality Control of Monoclonal Antibody[J]. China Biotechnology, 2019, 39(10): 105-110.
[2] Sai-bao LIU,Ya-fang LI,Hui WANG,Wei WANG,Duo-liang RAN,Hong-yan CHEN,Qing-wen MENG. Construction of Influenza Virus High-producing Cell Line MDCK-Tpl2 -/- with CRISPR / Cas9[J]. China Biotechnology, 2019, 39(1): 46-54.
[3] Ying CHEN,Hai-peng XIAO,Xiao-yan ZHANG,Qing-wei GONG,Li MA,Wen-jia LI,Xiao-feng CHEN. Expression and Characterization of Recombinant GLP-1-IgG4-Fc Fusion Protein[J]. China Biotechnology, 2018, 38(7): 58-66.
[4] CAO Rong-yue, YU Min-xia, ZHANG Xin-li, LI Man-man, MIAO Zi-tao, JIN Liang. Construction,Expression,Purification of VEGFⅡ/GRP Fusion Protein and the Effects on RM-1 Prostate Tumor in Mice[J]. China Biotechnology, 2016, 36(8): 9-15.
[5] CHEN Hua-xin, WU Jing, ZHAO Jin, JIANG Peng. Expression and Characterization of Fusion Protein of Single-chain Variable Fragment of Alpha Fetoprotein and Allophycocyanin Alpha Subunit[J]. China Biotechnology, 2016, 36(5): 74-80.
[6] GAO Xiang-lei, LIN Shu-shan, GONG Qing-wei, PAN Lan, MA Li, FENG Yan, LIN Xiao-que, ZENG Jian, LI Wen-jia, CHEN Xiao-feng, CHEN Ying. Purification and Characterization of Recombinant Human Glucagon-like Peptide-1 Analogue[J]. China Biotechnology, 2016, 36(12): 15-20.
[7] QIAN Jian ying, XU Zheng hong, DOU Wen fang. Study on the Preparation Technology of Injectable Powder of Fusion Protein GGH[J]. China Biotechnology, 2016, 36(11): 48-53.
[8] WANG Dian-liang. The Standards and Quality Control of Cell Drug[J]. China Biotechnology, 2016, 36(10): 115-121.
[9] GONG Long-cai, LUO Zhen-ming, YANG Yan-qing, WANG Zhen-yu, XIANG Jun-jian, WANG Hong. Prokaryotic Expression and Identification of cTnI-linker-TnC Fusion Protein[J]. China Biotechnology, 2015, 35(4): 48-53.
[10] YAN Li, WANG Kang, LI Rui-jian, BAI Yi, BAI Xian-hong, ZHOU Hai-ping. Manufaction of a New High-glycosylated Fusion Protein NESP-Fc[J]. China Biotechnology, 2015, 35(4): 80-85.
[11] LI Xing, YAO Wen-bing, XU Chen. Quality Control for PEGylated Recombinant Protein[J]. China Biotechnology, 2015, 35(12): 109-114.
[12] AI Jun, JIANG Chao, LIU Min, WANG Xiao-yan, TIAN Hai-shan, LI Xiao-kun. Two Oleosins Flanking the KGF-2 Improve the Expression Level of KGF-2 in Arabidopsis thaliana and Its Activity Analysis[J]. China Biotechnology, 2015, 35(1): 21-26.
[13] SHAO Yu, QU Guo-long, JIN Jing, WANG Wei, TAN Jun-jie, KAN Nai-peng, LI Yu-xia, LIU Gang, CHEN Hui-peng. Rapid Assembly of Long-term HSA/Exendin 4 Fusion Protein via BglBrick Method[J]. China Biotechnology, 2014, 34(4): 59-64.
[14] WANG Lan, XIA Mao, GAO Kai. The Development and Quality Control of Antibody-Drug Conjugates[J]. China Biotechnology, 2014, 34(4): 85-94.
[15] YANG Fan, HUANG Hu, LI Yi-chen, DENG Heng-lu, WU Mao-bo, ZHONG Ling, HOU Yong-min. Purification, Characterization and Pharmacokinetic Study of a Novel Long-acting Follicle-stimulating Hormone[J]. China Biotechnology, 2014, 34(2): 45-51.